ZDoggMD on Obesity Medicine: Why "Just Eat Less, Move More" Isn't Medical Advice

This article discusses ideas from ZDoggMD — Dr. Zubin Damania, MD , Stanford/UCSF-trained internist, founder of the Health 3.0 movement. Full archive: zdoggmd.com | YouTube @zdoggmd

ZDoggMD has taken a clear position on obesity medicine: it is a chronic disease with biological underpinnings that respond to medical treatment, not a character flaw that responds to lectures. The "just eat less, move more" advice that patients with obesity have received for decades is not medical guidance — it's the biomedical equivalent of telling a depressed patient to cheer up.

The Biology That Medicine Ignored for Decades

Obesity involves complex hormonal, neurological, and metabolic pathways that regulate appetite, energy expenditure, and fat storage. GLP-1, leptin, ghrelin, and insulin are all players in a system that has been shown to respond differently in people with obesity than in lean individuals — and to resist weight loss attempts through mechanisms that operate below conscious control.

When people lose weight through caloric restriction, the body responds with increased hunger signals, decreased metabolic rate, and hormonal changes that drive weight regain. This is why long-term weight loss maintenance through diet and exercise alone has such poor outcomes — the biology actively fights it. Treating this as a willpower problem rather than a biological one is both scientifically inaccurate and medically harmful.

GLP-1 Medications and the New Era of Obesity Treatment

ZDoggMD has discussed GLP-1 receptor agonists (semaglutide/Ozempic/Wegovy, tirzepatide/Mounjaro/Zepbound) extensively as a genuine advance in obesity medicine. The clinical trial data shows 15–22% body weight reduction — effects that are simply not achievable through lifestyle intervention alone for most patients with severe obesity.

His honest take includes the caveats: these medications work while you take them, weight returns when you stop, access and cost are significant barriers, and the long-term data on cardiovascular outcomes continues to accumulate but is still developing for the newer agents. The medications are a genuine advance; they're not a miracle with no complexity.

What ZDoggMD's Health 3.0 Approach Looks Like

Treat obesity as the chronic disease it is. Use medications when they're indicated, as we would for hypertension or diabetes. Integrate behavioral and nutritional support as adjuncts, not the primary treatment. Stop moralizing. Stop attributing poor outcomes to lack of patient effort when the biology explains the outcomes better than personal failure does.

ZDoggMD on obesity medicine and GLP-1 medications:

Obesity Medicine is Documentation-Heavy

Medication management, prior auth for GLP-1s, diet counseling, comorbidity tracking — obesity medicine generates significant charting burden. NoPajamaTime handles it in real time.